Form 4 for PVLA PALVELLA THERAPEUTICS, INC.
Accepted 2021-09-01 00:00:00 ET · period of report 2021-08-30 · accession 0001562180-21-005712 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-01 | 2021-08-30 | PVLA | Olwill Shane | Chief Development Off | M - OptEx | $1.52 | +38.4K | 43.0K | +828% | +$58.4K |
| DM | 2021-09-01 | 2021-08-30 | PVLA | Olwill Shane | Chief Development Off | S - Sale+OE | $5.11 | -38.4K | 33.8K | -53% | -$196.4K |
| D | 2021-09-01 | 2021-08-30 | PVLA | Olwill Shane | Chief Development Off | M - OptEx | $0.00 | -38.4K | 61.6K | -38% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-30 | M | A | 38,400 | $1.52 | 43,038 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-30 | S | D | 29,200 | $5.15 | 4,638 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.07 to $5.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above. |
| 3 | Common | Common Stock | 2021-08-30 | S | D | 9,200 | $5.00 | 33,838 | D | — | — | |
| 4 | Derivative | Stock Option (right to buy) | 2021-08-30 | M | D | 38,400 | $0.00 | 61,600 | D | $1.52 · — to 2026-02-12 | 100,000 Common Stock | (F2) The option has fully vested. |